View up-to-date information on Arrowhead Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
25 Apr 2022 | Visirna Therapeutics Enters into Licensing Agreement with Arrowhead Pharma | Licensing Agreement |
Visirna Therapeutics Inc
|
Arrowhead Pharmaceuticals Inc |
25 Apr 2022 | Arrowhead Pharma and Vivo Capital Form Joint Venture | Partnership |
Visirna Therapeutics Inc
|
Arrowhead Pharmaceuticals Inc
Vivo Capital LLC
|
22 Nov 2021 | GlaxoSmithKline Enters into Licensing Agreement with Arrowhead Pharma | Licensing Agreement |
GSK plc
|
Arrowhead Pharmaceuticals Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer